We’re thrilled to present the inaugural edition of The ReFocus Roundtable, a newsletter dedicated to showcasing the brilliance of our trusted network of over 140 ophthalmologists and optometrists. Spanning 62 locations across six states, ReFocus Eye Health brings together world-class specialists who are passionate about elevating patient care and advancing the field of ophthalmology.
Collaborating for Better Patient Outcomes
At the heart of ReFocus Eye Health lies a commitment to innovation and collaboration. This newsletter serves as a platform for our specialists to share insights, explore advancements, and highlight cutting-edge techniques in eye care. From routine exams to advanced treatments for cataracts, glaucoma, and diabetic retinopathy, our experts are setting new standards in vision health.
Highlights from This Issue
This edition delves into a broad array of topics, underscoring the depth of expertise and innovation within our network.
Here’s a snapshot of what’s covered:
- Minimally Invasive Glaucoma Surgery (MIGS): Highlighting groundbreaking techniques that bridge the gap for patients with mild to moderate glaucoma, offering safer, more efficient alternatives to traditional surgeries.
- Office-Based Surgery: Discover how procedures like cataract and refractive lens surgeries are becoming more convenient and patient-friendly with state-of-the-art office-based surgical suites, ensuring comfort without compromising safety.
- Selective Laser Trabeculoplasty (SLT): A revolutionary approach for glaucoma management, this procedure offers a non-invasive, drop-free solution that is safe, effective, and can be performed in minutes.
- Retinal Gene Therapy: The future is here with gene therapy for inherited retinal conditions and diseases like age-related macular degeneration. Learn how these therapies are restoring hope for previously untreatable conditions.
- Myopia Progression Prevention: With myopia rates climbing globally, advancements like MiSight contact lenses and diluted atropine treatments are making significant strides in slowing progression and preserving long-term vision.
- Advances in the Treatment of Geographic Atrophy: The newsletter explores FDA-approved therapies that target the complement system to slow the progression of this advanced form of age-related macular degeneration.
- Clinical Trials and Research Initiatives: Learn about our commitment to innovation through new clinical trials, such as the groundbreaking Phase 3 study on a small molecule tyrosine kinase inhibitor for wet AMD. Our research highlights the dedication of ReFocus Eye Health specialists to staying at the forefront of ophthalmic care.
Spotlighting Our Specialists
Behind these advancements are the visionaries of ReFocus Eye Health—dedicated professionals who are redefining the standards of care. Whether it’s leading clinical trials, pioneering innovative procedures, or sharing new approaches to patient management, our contributors exemplify excellence. Each brings unique expertise, but all share a singular goal: to improve outcomes and enhance quality of life for every patient.
A Shared Vision for the Future
At ReFocus Eye Health, we believe that collaboration fuels innovation. By sharing our knowledge and experiences, we empower our team to continually improve patient outcomes and enhance the quality of care. The ReFocus Roundtable is just one way we’re fostering this shared vision, bringing together expertise, compassion, and the latest in eye care excellence.
Stay tuned for more insights from our team of visionaries, and thank you for trusting us with your eye health. Together, we’re redefining what it means to see clearly.